EGFR and non-small cell lung carcinoma: Moreover, GC and epidermal growth factor receptor (EGFR)-mutant NSCLC are still serious public health problems in China (the incidence is far higher than in Europe and America) (Sung, Ferlay & Siegel, 2021; Xu et al., 2020).